Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Nicole Arradaza"'
Autor:
Pawan Kumar, Theodoros N. Teknos, Nicole Arradaza, Alessandra C. Schmitt, Michael J. Cipolla, James C. Lang, Arti Yadav, Bhavna Kumar
PDF file, 30KB.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7ede5c998b89eda6e8cdbe99fab017d
https://doi.org/10.1158/1535-7163.22497970.v1
https://doi.org/10.1158/1535-7163.22497970.v1
Autor:
Pawan Kumar, Theodoros N. Teknos, Nicole Arradaza, Alessandra C. Schmitt, Michael J. Cipolla, James C. Lang, Arti Yadav, Bhavna Kumar
PDF file, 2741KB, YM155 treatment induces survivin migration to nucleus in a time-dependent manner. CAL27-CisR cells were treated with YM155 (10 nM) for different time intervals and survvin localization was examined by staining these cells with survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af9815e91804a78df0dbbc9cc4416ce3
https://doi.org/10.1158/1535-7163.22497982.v1
https://doi.org/10.1158/1535-7163.22497982.v1
Autor:
Pawan Kumar, Theodoros N. Teknos, Nicole Arradaza, Alessandra C. Schmitt, Michael J. Cipolla, James C. Lang, Arti Yadav, Bhavna Kumar
PDF file, 34KB, Patient tumor characteristics (Group 1).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c29bd1c1791637e0440b689ac44bef9
https://doi.org/10.1158/1535-7163.22497967
https://doi.org/10.1158/1535-7163.22497967
Autor:
Pawan Kumar, Theodoros N. Teknos, Nicole Arradaza, Alessandra C. Schmitt, Michael J. Cipolla, James C. Lang, Arti Yadav, Bhavna Kumar
Cisplatin is one of the commonly used chemotherapeutic drugs for the treatment of head and neck squamous cell carcinoma (HNSCC). However, acquisition of cisplatin resistance is common in patients with HNSCC, and it often leads to local and distant fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e35cb94de9f251bd4dac90c596635af
https://doi.org/10.1158/1535-7163.c.6535759.v1
https://doi.org/10.1158/1535-7163.c.6535759.v1
Autor:
Pawan Kumar, Theodoros N. Teknos, Nicole Arradaza, Alessandra C. Schmitt, Michael J. Cipolla, James C. Lang, Arti Yadav, Bhavna Kumar
PDF file, 828KB, YM155 treatment does not significantly affect mice body weight. Mice weights were measured on days 9, 18, 27 and 36.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d69a1ef28eabfc49b60d310e63788af
https://doi.org/10.1158/1535-7163.22497973
https://doi.org/10.1158/1535-7163.22497973
Autor:
Pawan Kumar, Theodoros N. Teknos, Nicole Arradaza, Alessandra C. Schmitt, Michael J. Cipolla, James C. Lang, Arti Yadav, Bhavna Kumar
PDF file, 2045KB, Patient tumor characteristics (Group 2).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35e54ac67103a16b17c19e9227273c07
https://doi.org/10.1158/1535-7163.22497964
https://doi.org/10.1158/1535-7163.22497964
Autor:
Pawan Kumar, Theodoros N. Teknos, Nicole Arradaza, Alessandra C. Schmitt, Michael J. Cipolla, James C. Lang, Arti Yadav, Bhavna Kumar
PDF file, 1581KB, HNSCC cell line characteristics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4651f09357f9b46ce9b4d2ee8fe20cd3
https://doi.org/10.1158/1535-7163.22497961
https://doi.org/10.1158/1535-7163.22497961
Autor:
Pawan Kumar, Theodoros N. Teknos, Nicole Arradaza, Alessandra C. Schmitt, Michael J. Cipolla, James C. Lang, Arti Yadav, Bhavna Kumar
PDF file, 995KB, YM155 inhibits tumor cell proliferation in a dose-dependent manner. Cell proliferation in tumor cells (UM-SCC-74A or CAL27-CisR) or human oral keratinocytes (HOK) was assessed by MTT assay after 72 hrs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ea265d0c5d3bcbb75d2e476a30b2d26
https://doi.org/10.1158/1535-7163.22497991.v1
https://doi.org/10.1158/1535-7163.22497991.v1
Autor:
Pawan Kumar, Theodoros N. Teknos, Nicole Arradaza, Alessandra C. Schmitt, Michael J. Cipolla, James C. Lang, Arti Yadav, Bhavna Kumar
PDF file, 5124KB, YM155 and cisplatin combination treatment significantly inhibits tumor cell motility. Tumor cell motility was examined by scratch assay.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bb5449666f9b4fdc7fddc464be555c6
https://doi.org/10.1158/1535-7163.22497979
https://doi.org/10.1158/1535-7163.22497979
Autor:
Pawan Kumar, Theodoros N. Teknos, Nicole Arradaza, Alessandra C. Schmitt, Michael J. Cipolla, James C. Lang, Arti Yadav, Bhavna Kumar
PDF file, 839KB, YM155 and cisplatin combination treatment significantly inhibits tumor cell proliferation. UM-SCC-74A cells were treated with YM155 or cisplatin (CDDP) alone or in combination. After 72 hrs, cell proliferation was assessed by MTT ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::858d6031e8f90e998c8c2c997f286501
https://doi.org/10.1158/1535-7163.22497988.v1
https://doi.org/10.1158/1535-7163.22497988.v1